The expression of androgen receptors was stated in 54% of the investigated samples (27/50 cases) of an ECA that contributed to low grade endometroid carcinomas in 60%, high grade endometroid carcinomas in 70%, serous carcinomas in 70%, carcinosarcomas in 50% and clear cell carcinomas in 20%. Here, AR is linked to clear cell adenocarcinoma.